脂肪变性
某种肠道细菌
非酒精性脂肪肝
TLR4型
杯状细胞
封堵器
内科学
内分泌学
肠道菌群
粘液
势垒函数
炎症
脂肪肝
促炎细胞因子
化学
生物
生物化学
医学
紧密连接
上皮
细胞生物学
疾病
生态学
遗传学
作者
Jiemin Fan,Jingyue Sun,Tingting Li,Xiaoxue Yan,Yihong Jiang
标识
DOI:10.1016/j.jff.2021.104859
摘要
Nonalcoholic fatty liver disease (NAFLD) has been demonstrated to be closely associated with intestinal barrier functions. The aim of this study is to investigate the effects of nuciferine on preventing hepatic steatosis with relation to intestinal barrier functions in HFD-fed rats. The results showed nuciferine mitigated body weight gain, hyperlipemia and hepatic steatosis with regulating lipid metabolic gene expressions. Meanwhile, nuciferine decreased LPS-induced inflammation through inhibiting TLR4/MyD88/NF-κB pathway and reinforced intestinal barriers through increasing occludin and zonula occluden-1 expression, goblet cells, mucin2 (MUC2) expression. Furthermore, we found that nuciferine changed the relative abundance of mucus-related microbiota (Akkmensia muciniphila, Ruminococcaceae) and LPS-producing microbiota (Desulfovibrionaceae), increased the concentration of fecal acetic acid and propionic acid accompanied by decreased fecal pH. Together, anti-NAFLD effects of nuciferine are related to improving multiple intestinal barrier functions. These findings imply that nuciferine could be a promising agent for NAFLD with a target towards gut-liver axis.
科研通智能强力驱动
Strongly Powered by AbleSci AI